BACKGROUND: The purpose of the study was to examine whether early repeated infections due to Trichomonas vaginalis among human immunuodeficiency virus (HIV)-positive and HIV-negative women are reinfections, new infections, or cases of treatment failure. METHODS:Women attending an HIV outpatient clinic and a family planning clinic in New Orleans, Louisiana, who had culture results positive for T. vaginalis were treated with 2 g of metronidazole under directly observed therapy. At 1 month, detailed sexual exposure and sexual partner treatment information was collected. Isolates from women who had clinical resistance (i.e., who tested positive for a third time after treatment at a higher dose) were tested for metronidazole susceptibility in vitro. RESULTS: Of 60 HIV-positive women with trichomoniasis, 11 (18.3%) were T. vaginalis positive 1 month after treatment. The 11 recurrences were classified as 3 probable reinfections (27%), 2 probable infections from a new sexual partner (18%), and 6 probable treatment failures (55%); 2 of the 6 patients who experienced probable treatment failure had isolates with mild resistance to metronidazole. Of 301 HIV-negative women, 24 (8.0%) were T. vaginalis positive 1 month after treatment. The 24 recurrences were classified as 2 probable reinfections (8%) and 22 probable treatment failures (92%); of the 22 patients who experienced probable treatment failure, 2 had strains with moderate resistance to metronidazole, and 1 had a strain with mild resistance to metronidazole. CONCLUSION: HIV-positive women were more likely to have sexual re-exposure than were HIV-negative women, although the rate of treatment failure was similar in both groups. High rates of treatment failure among both HIV-positive and HIV-negative women indicate that a 2-g dose of metronidazole may not be adequate for treatment of some women and that rescreening should be considered.
RCT Entities:
BACKGROUND: The purpose of the study was to examine whether early repeated infections due to Trichomonas vaginalis among humanimmunuodeficiency virus (HIV)-positive and HIV-negative women are reinfections, new infections, or cases of treatment failure. METHODS:Women attending an HIV outpatient clinic and a family planning clinic in New Orleans, Louisiana, who had culture results positive for T. vaginalis were treated with 2 g of metronidazole under directly observed therapy. At 1 month, detailed sexual exposure and sexual partner treatment information was collected. Isolates from women who had clinical resistance (i.e., who tested positive for a third time after treatment at a higher dose) were tested for metronidazole susceptibility in vitro. RESULTS: Of 60 HIV-positive women with trichomoniasis, 11 (18.3%) were T. vaginalis positive 1 month after treatment. The 11 recurrences were classified as 3 probable reinfections (27%), 2 probable infections from a new sexual partner (18%), and 6 probable treatment failures (55%); 2 of the 6 patients who experienced probable treatment failure had isolates with mild resistance to metronidazole. Of 301 HIV-negative women, 24 (8.0%) were T. vaginalis positive 1 month after treatment. The 24 recurrences were classified as 2 probable reinfections (8%) and 22 probable treatment failures (92%); of the 22 patients who experienced probable treatment failure, 2 had strains with moderate resistance to metronidazole, and 1 had a strain with mild resistance to metronidazole. CONCLUSION: HIV-positive women were more likely to have sexual re-exposure than were HIV-negative women, although the rate of treatment failure was similar in both groups. High rates of treatment failure among both HIV-positive and HIV-negative women indicate that a 2-g dose of metronidazole may not be adequate for treatment of some women and that rescreening should be considered.
Authors: Arlene C Seña; William C Miller; Marcia M Hobbs; Jane R Schwebke; Peter A Leone; Heidi Swygard; Julius Atashili; Myron S Cohen Journal: Clin Infect Dis Date: 2006-11-27 Impact factor: 9.079
Authors: Susan Cu-Uvin; Hyejin Ko; Denise J Jamieson; Joseph W Hogan; Paula Schuman; Jean Anderson; Robert S Klein Journal: Clin Infect Dis Date: 2002-04-22 Impact factor: 9.079
Authors: Ivana V Radonjic; Aleksandar M Dzamic; Sanja M Mitrovic; Valentina S Arsic Arsenijevic; Dusan M Popadic; Ivana F Kranjcic Zec Journal: Eur J Obstet Gynecol Reprod Biol Date: 2005-10-24 Impact factor: 2.435
Authors: R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten Journal: J Infect Dis Date: 2007-01-22 Impact factor: 5.226
Authors: Patricia Kissinger; Norine Schmidt; Hamish Mohammed; Jami S Leichliter; Thomas L Gift; Bernadette Meadors; Cheryl Sanders; Thomas A Farley Journal: Sex Transm Dis Date: 2006-07 Impact factor: 2.830
Authors: Tracey E Wilson; Joseph Feldman; Miriam Y Vega; Monica Gandhi; Jean Richardson; Mardge H Cohen; Rosemary McKaig; David Ostrow; Esther Robison; Stephen J Gange Journal: AIDS Educ Prev Date: 2007-04
Authors: Megan Gatski; David H Martin; Judy Levison; Leandro Mena; Rebecca A Clark; Mary Murphy; Harold Henderson; Norine Schmidt; Patricia Kissinger Journal: Sex Transm Infect Date: 2011-01-29 Impact factor: 3.519
Authors: Megan Gatski; Leandro Mena; Judy Levison; Rebecca A Clark; Harold Henderson; Norine Schmidt; Susan L Rosenthal; David H Martin; Patricia Kissinger Journal: Sex Transm Dis Date: 2010-08 Impact factor: 2.830
Authors: Patricia Kissinger; Leandro Mena; Judy Levison; Rebecca A Clark; Megan Gatski; Harold Henderson; Norine Schmidt; Susan L Rosenthal; Leann Myers; David H Martin Journal: J Acquir Immune Defic Syndr Date: 2010-12-15 Impact factor: 3.731
Authors: Aida A Abdel-Magied; El-Said I El-Kholya; Salwa M Abou El-Khair; Eman S Abdelmegeed; Marwa M Hamoudaa; Sara A Mohamed; Nora Labeeb El-Tantawy Journal: Parasitol Res Date: 2017-09-27 Impact factor: 2.289
Authors: Megan Clare Craig-Kuhn; Charleigh Granade; Christina A Muzny; Barbara Van Der Pol; Rebecca Lillis; Stephanie N Taylor; Norine Schmidt; David H Martin; Patricia Kissinger Journal: Sex Transm Dis Date: 2019-05 Impact factor: 2.830
Authors: Jennifer E Balkus; Barbra A Richardson; Vernon Mochache; Vrasha Chohan; Jeannie D Chan; Linnet Masese; Juma Shafi; Jeanne Marrazzo; Carey Farquhar; R Scott McClelland Journal: Sex Transm Dis Date: 2013-06 Impact factor: 2.830
Authors: Patricia Kissinger; Alys Adamski; Rebecca A Clark; Leandro Mena; Judy Levison; David H Martin Journal: Sex Transm Dis Date: 2013-06 Impact factor: 2.830
Authors: Brandon L Guthrie; James N Kiarie; Susan Morrison; Grace C John-Stewart; John Kinuthia; William L H Whittington; Carey Farquhar Journal: PLoS One Date: 2009-12-14 Impact factor: 3.240